We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn about our cookie policy.
Sigma-Aldrich NANOFABTX(TM)- RGD LIPID MIX FOR SYNTH&
List Price $302.00 Your Price $302.00
Sigma-Aldrich NANOFABTX(TM)- RGD LIPID MIX FOR SYNTH& - SIALUPENN (Additional S&H or Hazmat Fees may Apply)
NETA PART: SIALUPENN-934224-25MG
MFG.PART: 934224-25MG
UNSPSC: 41122409
Manufacturer: Sigma-Aldrich


Quality Level
100
storage temp.
−20°C
Application
NanoFabTx™ RGD Lipid Mix is a ready-to-use curated lipid mixture containing rationally selected lipids and step by step instructions for synthesizing RGD functionalized liposomes or lipid nanoparticles. RGD is a peptide composed of arginine, glycine, and aspartic acid (Arg-Gly-Asp).
RGD has high affinity to integrins (including alpha V beta 3) which are overexpressed on cancer cells such as glioma, ovarian cancer, breast cancer, pancreatic cancer to name a few. RGD conjugated lipids can be used to prepare liposomes to achieve targeted delivery of the anti-cancer agents to the cells which overexpress these receptors. The cells will internalize the RGD containing peptide via integrin-mediated endocytosis. As a result, the targeted liposomes avoid off target effects, a major side effect of many cancer therapies.
The RGD-functionalized liposomes synthesized from the NanoFabTx™ RGD Lipid Mix enable users to 1) encapuslate a wide variety of small molecules and 2) selectively target cells which overexpress RGD-binding integrins, such as cancer cells, without the need for lengthy trial-and-error optimization.
RGD has high affinity to integrins (including alpha V beta 3) which are overexpressed on cancer cells such as glioma, ovarian cancer, breast cancer, pancreatic cancer to name a few. RGD conjugated lipids can be used to prepare liposomes to achieve targeted delivery of the anti-cancer agents to the cells which overexpress these receptors. The cells will internalize the RGD containing peptide via integrin-mediated endocytosis. As a result, the targeted liposomes avoid off target effects, a major side effect of many cancer therapies.
The RGD-functionalized liposomes synthesized from the NanoFabTx™ RGD Lipid Mix enable users to 1) encapuslate a wide variety of small molecules and 2) selectively target cells which overexpress RGD-binding integrins, such as cancer cells, without the need for lengthy trial-and-error optimization.
Features and Benefits
- A ready-to-use lipid blend for the synthesis of RGD targeted liposomes
- Step-by-step protocols (extrusion, microfluidics) developed and tested by our formulation scientists
- Flexible synthesis tool to create uniform and reproducible liposomes
- RGD ligand enables targeted drug delivery
- A lipid film hydration and extrusion protocol
- A microfluidics protocol using commercial platforms or syringe pumps
For more information, please refer to the protocol under the Protocol section of this page.
Legal Information
NANOFABTX is a trademark of Sigma-Aldrich Co. LLC
Storage Class
11 - Combustible Solids
wgk_germany
WGK 3
| SKU | SIALUPENN-934224-25MG |
|---|---|
| Supplier Part Number | 934224-25MG |
| UM | EA |
| UNSPSC | 41122409 |
| Manufacturer | Sigma-Aldrich |
| ProductLine | SIALUPENN |
| Qty | 1 |
| MinOrderQty | 1 |
| Weight | 7.000000 |
| Lead Time | 3 |
| Hazardous | N |
| Energy Star | No |
| Green | No |
| Controlled | N |

